Guardant Health, Inc. [GH] saw a change by -5.22% with the Thursday trading session, closing the trade at the price of $76.50. The company is holding 94.22M shares with keeping 83.65M floating shares. With the latest trading session, the stock is set at 182.91% off compared to its 52-week low, sliding -31.83% from high for the same period of time.

Since its 90-day high, the share price saw a move by -31.83%, trading +2.84% in oppose to its 90-day low While during the day, 94.22M shares valued at 2.56 million were bought and sold.

Guardant Health, Inc. [NASDAQ:GH]: Analyst Rating and Earnings

Its stock price has been found in the range of 27.04 to 112.21. This is compared to its latest closing price of $80.71.

Keep your eyes peeled for the next scheduled financial results to be made public for this company, which are scheduled to be released on Mon 18 Nov (In 68 Days).

Fundamental Analysis of Guardant Health, Inc. [GH]

Now let’s turn to look at profitability: with a current Operating Margin for Guardant Health, Inc. [GH] sitting at -102.54 and its Gross Margin at +52.33, this company’s Net Margin is now -60.10%. These metrics indicate that this company is not generating as much profit, after accounting for expenses, compared to its market peers.

This company’s Return on Total Capital is -21.88, and its Return on Invested Capital has reached -18.40%. Its Return on Equity is -21.49, and its Return on Assets is -18.29. These metrics suggest that this Guardant Health, Inc. does a poor job of managing its assets, and likely won’t be able to provide successful business outcomes for its investors in the near term.

Turning to investigate this organization’s capital structure, Guardant Health, Inc. [GH] has generated a Total Debt to Total Equity ratio of 1.56. Similarly, its Total Debt to Total Capital is 1.54, while its Total Debt to Total Assets stands at 1.29. Looking toward the future, this publicly-traded company’s Long-Term Debt to Equity is -74.29, and its Long-Term Debt to Total Capital is 1.54.

What about valuation? This company’s Enterprise Value to EBITDA is -84.76. The Enterprise Value to Sales for this firm is now 50.09, and its Total Debt to Enterprise Value stands at 0.01. Guardant Health, Inc. [GH] has a Price to Book Ratio of 6.68.

Shifting the focus to workforce efficiency, Guardant Health, Inc. [GH] earns $199,645 for each employee under its payroll. Similarly, this company’s Receivables Turnover is 3.74 and its Total Asset Turnover is 0.19. This publicly-traded organization’s liquidity data is also interesting: its Quick Ratio is 9.80 and its Current Ratio is 9.99. This company, considering these metrics, has a healthy ratio between its short-term liquid assets and its short-term liabilities, making it a less risky investment.

Guardant Health, Inc. [GH] has 94.22M shares outstanding, amounting to a total market cap of $7.21B. Its stock price has been found in the range of 27.04 to 112.21. At its current price, it has moved down by -31.83% from its 52-week high, and it has moved up 182.91% from its 52-week low.

This stock’s Relative Strength Index (RSI) is at 31.44. This RSI score is good, suggesting this stock is neither overbought or oversold.

Conclusion: Is Guardant Health, Inc. [GH] a Reliable Buy?

Shares of Guardant Health, Inc. [GH], on the whole, present investors with both positive and negative signals. Wall Street analysts have mixed reviews when it comes to the 12-month price outlook, and this company’s financials show a combination of strengths and weaknesses. Based on the price performance, this investment is somewhat risky while presenting reasonable potential for ROI.